Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. NeuroOne Medical Technologies Corp shares valued at $22,203 were sold by Christianson Mark on Sep 05 ’25. At $0.74 per share, Christianson Mark sold 30,000 shares. The insider’s holdings dropped to 231,238 shares worth approximately $0.21 million following the completion of this transaction.
Also, Christianson Mark purchased 30,000 shares, netting a total of over 24,210 in proceeds.
Before that, Christianson Mark had sold 10,000 shares from its account. In a trade valued at $5,804, the Business Development Director traded NeuroOne Medical Technologies Corp shares for $0.58 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.23 million.
As published in their initiating research note from Ladenburg Thalmann on May 05, 2025, NeuroOne Medical Technologies Corp [NMTC] has been a Buy and the price target has been revised to $1.45. Analysts at Craig Hallum downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late March.
Analyzing NMTC Stock Performance
On last trading session, NeuroOne Medical Technologies Corp [NASDAQ: NMTC] plunged -0.82% to $0.89. The stock’s lowest price that day was $0.8437, but it reached a high of $0.9318 in the same session. During the last five days, there has been a surge of approximately 17.73%. Over the course of the year, NeuroOne Medical Technologies Corp shares have dropped approximately -14.19%. Shares of the company reached a 52-week high of $1.0200 on 01/06/26 and a 52-week low of $0.7580 on 01/02/26.
Support And Resistance Levels for NeuroOne Medical Technologies Corp (NMTC)
According to the 24-hour chart, there is a support level at 0.8468, which, if violated, would cause prices to drop to 0.8012. In the upper region, resistance lies at 0.9349. The next price resistance is at 0.9774. RSI (Relative Strength Index) is 61.49 on the 14-day chart, showing neutral technical sentiment.
Is NeuroOne Medical Technologies Corp subject to short interest?
Stocks of NeuroOne Medical Technologies Corp saw a sharp rise in short interest on 2025-12-15 jumping by 57609.0 shares to 0.11 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 47824.0 shares. A jump of 54.64% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.51 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.51.
Which companies own the most shares of NeuroOne Medical Technologies Corp (NMTC)?
In terms of NeuroOne Medical Technologies Corp share price expectations, FactSet research, analysts set an average price target of 3 in the next 12 months, up nearly 233.33% from the previous closing price of $0.9. Analysts anticipate NeuroOne Medical Technologies Corp stock to reach 3 by 2026, with the lowest price target being 3.
